Impact of drug development on the use of stem cell transplantation: a report by the European Society for Blood and Marrow Transplantation (EBMT).
about
Interleukin-6 in Allogeneic Stem Cell Transplantation: Its Possible Importance for Immunoregulation and As a Therapeutic Target.Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report.Pharmacotherapy of relapsed/refractory chronic lymphocytic leukemia.Who Is the Patient at Risk of CMV Recurrence: A Review of the Current Scientific Evidence with a Focus on Hematopoietic Cell Transplantation.Reduced-intensity conditioning allogeneic transplantation after salvage treatment with DT-PACE in myeloma patients relapsing early after autologous transplant.
P2860
Impact of drug development on the use of stem cell transplantation: a report by the European Society for Blood and Marrow Transplantation (EBMT).
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Impact of drug development on ...... Marrow Transplantation (EBMT).
@en
Impact of drug development on ...... ood and Marrow Transplantation
@nl
type
label
Impact of drug development on ...... Marrow Transplantation (EBMT).
@en
Impact of drug development on ...... ood and Marrow Transplantation
@nl
prefLabel
Impact of drug development on ...... Marrow Transplantation (EBMT).
@en
Impact of drug development on ...... ood and Marrow Transplantation
@nl
P2093
P2860
P50
P356
P1476
Impact of drug development on ...... Marrow Transplantation (EBMT)
@en
P2093
D Farge-Bancel
H Baldomero
P2860
P2888
P304
P356
10.1038/BMT.2016.258
P407
P577
2016-11-07T00:00:00Z